A retrospective cohort investigation of seroprevalence of Marburg virus and ebolaviruses in two different ecological zones in Uganda

[1]  A. Schuh,et al.  Egyptian rousette bats maintain long-term protective immunity against Marburg virus infection despite diminished antibody levels , 2017, Scientific Reports.

[2]  F. Checchi,et al.  Asymptomatic infection and unrecognised Ebola virus disease in Ebola-affected households in Sierra Leone: a cross-sectional study using a new non-invasive assay for antibodies to Ebola virus. , 2017, The Lancet. Infectious diseases.

[3]  J. Glynn,et al.  A systematic review and meta-analysis of seroprevalence surveys of ebolavirus infection , 2017, Scientific Data.

[4]  L. Nyakarahuka,et al.  How severe and prevalent are Ebola and Marburg viruses? A systematic review and meta-analysis of the case fatality rates and seroprevalence , 2016, BMC Infectious Diseases.

[5]  Sarah L. Keasey,et al.  Human Survivors of Disease Outbreaks Caused by Ebola or Marburg Virus Exhibit Cross-Reactive and Long-Lived Antibody Responses , 2016, Clinical and Vaccine Immunology.

[6]  L. Hooper,et al.  Risk factors for transmission of Ebola or Marburg virus disease: a systematic review and meta-analysis , 2015, International journal of epidemiology.

[7]  A. Mbonye,et al.  Multidistrict Outbreak of Marburg Virus Disease-Uganda, 2012. , 2015, The Journal of infectious diseases.

[8]  W. Team Ebola Virus Disease in West Africa — The First 9 Months of the Epidemic and Forward Projections , 2014 .

[9]  A. Schuh,et al.  Marburgvirus Resurgence in Kitaka Mine Bat Population after Extermination Attempts, Uganda , 2014, Emerging infectious diseases.

[10]  Mikiko Senga,et al.  Ebola virus disease in West Africa--the first 9 months of the epidemic and forward projections. , 2014, The New England journal of medicine.

[11]  Timothy D. Flietstra,et al.  Seasonal Pulses of Marburg Virus Circulation in Juvenile Rousettus aegyptiacus Bats Coincide with Periods of Increased Risk of Human Infection , 2012, PLoS pathogens.

[12]  P. Formenty,et al.  Outbreak of Marburg hemorrhagic fever among miners in Kamwenge and Ibanda Districts, Uganda, 2007. , 2011, The Journal of infectious diseases.

[13]  N. Wauquier,et al.  Risk factors for Zaire ebolavirus--specific IgG in rural Gabonese populations. , 2011, The Journal of infectious diseases.

[14]  A. MacNeil,et al.  Serologic Cross-Reactivity of Human IgM and IgG Antibodies to Five Species of Ebola Virus , 2011, PLoS neglected tropical diseases.

[15]  N. Wauquier,et al.  High Prevalence of Both Humoral and Cellular Immunity to Zaire ebolavirus among Rural Populations in Gabon , 2010, PloS one.

[16]  Alan Kemp,et al.  Isolation of Genetically Diverse Marburg Viruses from Egyptian Fruit Bats , 2009, PLoS pathogens.

[17]  A. Viera Odds ratios and risk ratios: what's the difference and why does it matter? , 2008, Southern medical journal.

[18]  S. Lahm,et al.  Morbidity and mortality of wild animals in relation to outbreaks of Ebola haemorrhagic fever in Gabon, 1994-2003. , 2007, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[19]  R. Hatchett,et al.  Low seroprevalence of IgG antibodies to Ebola virus in an epidemic zone: Ogooué-Ivindo region, Northeastern Gabon, 1997. , 2005, The Journal of infectious diseases.

[20]  J. Gonzalez,et al.  Ebola Virus Antibody Prevalence in Dogs and Human Risk , 2005, Emerging infectious diseases.

[21]  H. Feldmann,et al.  Evidence for occurrence of filovirus antibodies in humans and imported monkeys: do subclinical filovirus infections occur worldwide? , 1992, Medical Microbiology and Immunology.

[22]  C. Roth,et al.  Risk Factors for Marburg Hemorrhagic Fever, Democratic Republic of the Congo , 2003, Emerging infectious diseases.

[23]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..

[24]  J. Gonzalez,et al.  Ebola and Marburg virus antibody prevalence in selected populations of the Central African Republic. , 2000, Microbes and infection.

[25]  M. Georges-Courbot,et al.  Leptospirosis and Ebola virus infection in five gold-panning villages in northeastern Gabon. , 1999, The American journal of tropical medicine and hygiene.

[26]  P. Jahrling,et al.  ELISA for the detection of antibodies to Ebola viruses. , 1999, The Journal of infectious diseases.

[27]  H. Feldmann,et al.  Prevalence of IgG antibodies to Ebola virus in individuals during an Ebola outbreak, Democratic Republic of the Congo, 1995. , 1999, The Journal of infectious diseases.

[28]  M. Georges-Courbot,et al.  Ebola hemorrhagic fever outbreaks in Gabon, 1994-1997: epidemiologic and health control issues. , 1999, The Journal of infectious diseases.

[29]  J. Gonzalez,et al.  Filovirus activity among selected ethnic groups inhabiting the tropical forest of equatorial Africa. , 1993, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[30]  J. Gonzalez,et al.  Haemorrhagic fever virus activity in equatorial Africa: distribution and prevalence of filovirus reactive antibody in the Central African Republic. , 1993, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[31]  S. Bennett,et al.  A simplified general method for cluster-sample surveys of health in developing countries. , 1991, World health statistics quarterly. Rapport trimestriel de statistiques sanitaires mondiales.

[32]  D. Fontenille,et al.  Antibodies to haemorrhagic fever viruses in Madagascar populations. , 1989, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[33]  J. Gonzalez,et al.  Antibody prevalence against haemorrhagic fever viruses in randomized representative Central African populations. , 1989, Research in virology.

[34]  J. McCormick,et al.  Viral hemorrhagic fever antibodies in Nigerian populations. , 1988, The American journal of tropical medicine and hygiene.

[35]  H. Fleury,et al.  [Serological study of the virus responsible for hemorrhagic fever in an urban population of Cameroon]. , 1988, Bulletin de la Societe de pathologie exotique et de ses filiales.

[36]  M. Georges-Courbot,et al.  [Current serologic data on viral hemorrhagic fevers in the Central African Republic]. , 1987, Bulletin de la Societe de pathologie exotique et de ses filiales.

[37]  D. Gajdusek,et al.  Hemorrhagic fever virus infections in an isolated rainforest area of central Liberia. Limitations of the indirect immunofluorescence slide test for antibody screening in Africa. , 1986, Tropical and geographical medicine.

[38]  P. Bourée,et al.  Ebola virus infection in man: a serological and epidemiological survey in the Cameroons. , 1983, The American journal of tropical medicine and hygiene.

[39]  J. McCormick,et al.  Ebola virus disease in southern Sudan: hospital dissemination and intrafamilial spread. , 1983, Bulletin of the World Health Organization.

[40]  P. Tukei,et al.  Antibodies against haemorrhagic fever viruses in Kenya populations. , 1983, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[41]  D. Heymann,et al.  Ebola hemorrhagic fever: Tandala, Zaire, 1977-1978. , 1980, The Journal of infectious diseases.

[42]  G. van der Groen,et al.  Measurement of antibodies to Ebola virus in human sera from N. W.-Zaire. , 1979, Annales de la Societe belge de medecine tropicale.